Anthony J. Guzzo Net Worth

Mr. Anthony J. Guzzo biography

Anthony J. Guzzo is the Principal Accounting Officer & Interim Principal Financial Officer at Phathom Pharmaceuticals Inc.

How old is Mr Guzzo?

Mr Guzzo is 48, he's been the Principal Accounting Officer & Interim Principal Financial Officer of Phathom Pharmaceuticals Inc since . There are 9 older and 4 younger executives at Phathom Pharmaceuticals Inc. The oldest executive at Phathom Pharmaceuticals Inc is Tadataka Yamada, 75, who is the Independent Chairman of the Board.

What's Mr Guzzo's mailing address?

Anthony's mailing address filed with the SEC is C/O PHATHOM PHARMACEUTICALS, INC., 100 CAMPUS DRIVE, SUITE 102, FLORHAM PAK, NJ, 07932.

Insiders trading at Phathom Pharmaceuticals Inc

Over the last 5 years, insiders at Phathom Pharmaceuticals Inc have traded over 112,538,769$ worth of Phathom Pharmaceuticals Inc stock and bought 2,393,679 units worth 45,337,731$ . The most active insiders traders include Capital Management, L.P.Ra ...、James N Topper、Pharmaceutical Co Ltd Takeda. On average, Phathom Pharmaceuticals Inc executives and independent directors trade stock every 24 days with the average trade being worth of 2,226,815$. The most recent stock trade was executed by Azmi Nabulsi on 15 July 2024, trading 10,901 units of PHAT stock currently worth 127,760$.

What does Phathom Pharmaceuticals Inc do?

phathom pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. the company has the rights in the united states, europe, and canada to vonoprazan, a potassium-competitive acid blocker (p-cab) that blocks acid secretion in the stomach. it is also developing vonoprazan, which is in phase iii clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of helicobacter pylori infection. the company was incorporated in 2018 and is based in buffalo grove, illinois.

Phathom Pharmaceuticals Inc executives and stock owners

Phathom Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Terrie Curran,
  President, Chief Executive Officer, Director
• Terrie J. Curran,
  Pres, CEO & Director
• Dr. Azmi Nabulsi M.D., M.P.H.,
  Co-Founder & COO
• David Socks,
  Co-Founder, Chief Financial Officer, Treasurer, Director
• Azmi Nabulsi,
  Co-Founder, Chief Operating Officer
• David A. Socks,
  Co-Founder & Director
• Michael Cola,
  Independent Director
• Heidi Kunz,
  Independent Director
• Aditya Kohli,
  Chief Business Officer and Co-founder
• Tadataka Yamada,
  Independent Chairman of the Board
• James Topper,
  Independent Director
• Mark Stenhouse,
  Independent Director
• Asit Parikh,
  Independent Director
• Martin J. Gilligan,
  Chief Commercial Officer
• Dr. Eckhard Leifke M.D., Ph.D.,
  Chief Medical Officer
• Tom Harris,
  Head of Regulatory Affairs
• Lawrence Miller Esq., J.D.,
  Gen. Counsel & Sec.
• Joseph Hand J.D.,
  Chief Admin. Officer
• Anthony J. Guzzo,
  Principal Accounting Officer & Interim Principal Financial Officer
• Aditya Kohli Ph.D.,
  Co-Founder
• Frank Karbe,
  
• Todd P. Branning,
  Chief Financial Officer
• Heidi Fields,
  
• Capital Management, L.P.Ra ...,
  
• Life Sciences Ix, L.P.Fhmls...,
  
• Life Sciences Ix, L.P.Toppe...,
  
• Jonathan S. Edwards,
  Director
• Pharmaceutical Co Ltd Takeda,
  10% owner
• Anthony J. Guzzo,
  VP, Chief Accounting Officer
• Molly Henderson,
  CFO and CBO